A Positron Emission Tomography study to assess the level and duration of occupancy of serotonin-1a receptors produced by single oral doses of SRA-444 in healthy elderly subjects and in subjects with Alzheimer disease

Trial Profile

A Positron Emission Tomography study to assess the level and duration of occupancy of serotonin-1a receptors produced by single oral doses of SRA-444 in healthy elderly subjects and in subjects with Alzheimer disease

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Jan 2010

At a glance

  • Drugs SRA 444 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 02 Jul 2008 The expected completion date for this trial has been extended from Jan 2008 to Jun 2008 as reported by ClinicalTrials.gov.
    • 02 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Dec 2007 Status change from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top